GENETWORx Looking to acquire or partner with Diagnostic Laboratories

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

King of Prussia, PA, March 17, 2023 (GLOBE NEWSWIRE) — GENETWORx, a private equity backed laboratory, announces it’s looking to buy or partner with other diagnostics laboratories.

GENETWORx is a clinical diagnostics laboratory based outside of Richmond, VA, that specializes in molecular pathogen and pharmacogenomic testing.  GENETWORx offers providers the information they needed to properly prescribe therapeutic options, resulting in improved outcomes.

“We are looking to acquire or strategically partner with laboratories to scale a national platform,” says Steve Crossley, CEO for GENETWORx. “As we look to the future of diagnostic testing, partnering with other laboratories will expand accessibility to patients and, ultimately, improve patient outcomes.  We’re excited to be a part of leading the future of diagnostic testing together.”

All opportunities will be considered.  Please contact Kevin Mullin at 610-994-2942 or Steve Crossley via email at labrequest@genetworx.com.

 ###

  

Molecular Pathogen Testing

Molecular PCR pathogen testing generates results that are more accurate than standard culture and sensitivity testing within 24-48 hours of lab receipt.[1] GENETWORx offers clear and concise reports that provide a picture of the type and percent of pathogens causing an infection and, in many cases, identifies antimicrobial resistance regardless of concurrent antibiotic use.

Pharmacogenomic Testing

Pharmacogenomic (PGx) testing is a DNA Medication-Response test that detects genetic differences that affect the metabolism of therapeutic medications and possibilities for adverse events. PGX testing provides pertinent information to ensure patients are prescribed the most effective medication based on drug-metabolism pathways. Understanding how patients metabolize medications and gene/drug interactions may help clinicians improve therapeutic efficacy and reduce adverse effects, while providing insight into potential therapy modifications in certain circumstances.[2]

About GENETWORx:

Located in Glen Allen, VA, GENETWORx is a fully integrated CAP accredited laboratory which is certified by the Clinical Laboratory Improvement Amendment (CLIA) for high complexity clinical diagnostic testing. The company is a full clinical diagnostics laboratory with an expansive test menu, including infectious disease testing, COVID-19 testing, and pharmacogenomic testing. GENETWORx provides a full range of diagnostic testing to healthcare facilities nationwide.


[1] Molecular Detection and Identification of Anaerobic Bacteria – Science Direct

[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068890/

 

CONTACT: Steve Crossley/Kevin Mullin
Genetworx
610-994-2942
labrequest@genetworx.com

Staff

Recent Posts

hūmānus and ARSPHR Launch Groundbreaking Rohingya Atrocities Archive, Continuing Mohibullah’s Sacrificial Fight for Truth and Justice

"If I die, it's okay. I will give my life for my community." Mohibullah LONDON, July…

1 hour ago

Seegene unveils the world’s first unattended PCR automation, igniting a global diagnostic paradigm shift at ADLM 2025

Fully Unmanned— CURECA™, the 100% Automated Diagnostic System Defining the Future Gold Standard, Debuts in Chicago,…

1 hour ago

Nutex Health Responds to Short Seller Report

HOUSTON, July 23, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:…

7 hours ago

Happy Docs Make Happy Patients

AI technology boosts face-to-face time with patients, earns Mercy national recognition for physician satisfaction ST.…

7 hours ago

Waystar to Acquire Iodine Software, Accelerating the AI-Powered Transformation of Healthcare Payments

Extends Waystar's AI leadership into clinical intelligence software, unlocking greater value for clients and shareholders Highly…

13 hours ago

HAMILTON BEACH BRANDS HOLDING COMPANY ANNOUNCES DATES OF ITS 2025 SECOND QUARTER EARNINGS RELEASE AND CONFERENCE CALL

GLEN ALLEN, Va., July 23, 2025 /PRNewswire/ -- Hamilton Beach Brands Holding Company (NYSE: HBB)…

13 hours ago